Showing 1 - 9 of 9
Regional shares sink as trade war worries mount
Business, Nuntawun Polkuamdee and Nareerat Wiriyapong, Published on 29/03/2025
» RECAP: Asian stocks slid yesterday with heavy selling in South Korea and Japan, while safe-haven gold traded at a record high as the latest tariff salvo from US President Donald Trump stoked investor worries of an all-out trade war.
Xi meets global business leaders as China seeks to woo investors
Bloomberg, Published on 28/03/2025
» Chinese President Xi Jinping met with a group of global business leaders in Beijing, in an effort to boost investor sentiment as rising tariffs fuel uncertainty for the economy and international trade.
French state, Sanofi face ruling in birth defects case
AFP, Published on 01/07/2020
» PARIS - A French court is scheduled to rule Wednesday on the responsibility of the French state in birth defects linked to an anti-epilepsy drug produced by pharmaceutical giant Sanofi.
Cases top 90,000, new drugs to come ‘in months’: Virus update
Bloomberg and online reporters, Published on 03/03/2020
» Governments from Japan to the UK prepared emergency measures or economic packages to fight the spread of the coronavirus. Drugmakers said they hope to have antiviral treatments ready within months and vaccines by next year.
J&J, Sanofi, Inovio Hunt for Coronavirus Vaccines
Business, Peter Loftus, Published on 26/02/2020
» Drugmakers Johnson & Johnson, Sanofi SA and Inovio Pharmaceuticals Inc. have started to develop coronavirus vaccines, and human studies of them could start in anywhere from a few months to about a year from now. The efforts come as Moderna Inc. has shipped a batch of its experimental coronavirus vaccine to U.S. researchers for human testing.
Deaths top 2,000, Chinese workers unpaid: Virus update
Bloomberg News, Published on 19/02/2020
» Hong Kong had a second fatality from the coronavirus while China’s death toll from the outbreak went past 2,000.
China drives down drug prices with bulk-buy bidding
Reuters and Bloomberg, Published on 18/01/2020
» BEIJING: Global pharmaceutical majors and generic drugmakers have slashed the prices of some of their off-patent products by an average of 53% in the latest bidding round under China’s national bulk-buying programme.
Sanofi names Novartis executive as new CEO
Business, Published on 08/06/2019
» France's biggest drugmaker Sanofi has appointed Novartis executive Paul Hudson to replace CEO Olivier Brandicourt who will retire in September.
European losers in new Iranian sanctions game
AFP, Published on 05/08/2018
» PARIS: US President Donald Trump's decision to pull the United States out of the 2015 nuclear accord with Iran and reimpose a raft of sanctions will hit European businesses working in Iran.